Matsumoto Yushi-Seiyaku Co., Ltd.
Notice of Executive Changes
Matsumoto Oil and Fat Pharmaceuticals plans to implement executive changes on June 25, 2026. The new candidate for Audit & Supervisory Board Member is Mr. Shinichiro Yamane, while Mr. Shuhei Kuge is scheduled to resign. These changes are expected to be officially approved at the General Meeting of Shareholders and the Board of Directors following the meeting.
Key Figures
- Scheduled date of executive change: June 25, 2026
- New candidate for Audit & Supervisory Board Member: Mr. Shinichiro Yamane
- Scheduled resignation of Audit & Supervisory Board Member: Mr. Shuhei Kuge
AI要約
Overview of Executive Changes
Matsumoto Oil and Fat Pharmaceuticals plans to implement executive changes effective June 25, 2026. The candidate for new Audit & Supervisory Board Member is Mr. Shinichiro Yamane, who is scheduled to be appointed as Full-time Auditor, and Mr. Shuhei Kuge is scheduled to resign from his position. These changes are expected to be formally approved at the Annual General Meeting of Shareholders held on June 25, 2026, and at the subsequent meeting of the Board of Directors.
Impact of Executive Changes and Future Outlook
The purpose of these executive changes is to strengthen the corporate governance structure, which is expected to contribute to the stability of management from the perspective of shareholders and investors. After formal approval, new developments in management policies and business strategies are anticipated; however, the specific impact on business operations remains currently unknown.
Matsumoto Oil and Fat Pharmaceuticals Co., Ltd.
Company overview · Stock price · Financial data · All IR
